Telmisartan, Amlodipine and Flow Mediated Dilation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 576 participants.
Also called NCT01180205
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 576 participants
- Registry
-
NCT01180205
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Unknown status
Technical summary
Registry record NCT01180205. Randomized; quadruple masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2011-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Telmisartan, Amlodipine and Flow Mediated Dilation
- Acronym
- TEAMSTAprotect
- Condition
- Hypertension
- Intervention (Drug)
- Telmisartan
- Intervention (Drug)
- Amlodipine
- Intervention (Drug)
- Olmesartan medoxomil
- Intervention (Drug)
- Hydrochlorothiazide
- Lead sponsor
- Johannes Gutenberg University Mainz
Record details
- Record id
cardio:ct-nct01180205- Content hash
dc0901ac32b815e293557c88d1c8f2266cb4f89c00c5ba61df2e64e4054ad947